Sleep Apnea Oral Appliances Market is Booming

Dr. Young of Monmouth and Ocean County, NJ Shares Sleep Apnea Oral Appliances Market is Booming

The latest report from MarketsandMarkets™ indicates that the Sleep Apnea Oral Appliances market, valued at $0.4 billion in 2023, is projected to expand to $0.9 billion by 2028, marking a significant CAGR of 15.2% during this period.

This growth is fueled by the increasing availability of personalized oral appliances and the collaboration between dentists and sleep specialists. However, concerns about the risks associated with obstructive sleep apnea treatment using oral appliances could hinder market growth.

Key Highlights:

* The Sleep Apnea Oral Appliances market is estimated to grow at a CAGR of 15.2% from 2023 to 2028, reaching $0.9 billion by 2028, up from $0.4 billion in 2023.

* The market segments include product, purchase type, gender, age group, distribution channel, and end user.

* North America, Europe, Asia-Pacific, and the Rest of the World are the geographic segments covered in the report, with North America leading the market share due to ongoing research and development initiatives and a rising aging population.

* The report categorizes the Sleep Apnea Oral Appliances market into segments such as product types, purchase types, gender, age groups, distribution channels, and end users.

Market Segmentation:

* Product Split: Mandibular Advancement Devices, Tongue Retaining Devices, Daytime Nighttime Appliance

* Purchase Type Split: Physician-prescribed/Customized oral appliances, Online OTC oral appliances

* Gender Split: Male, Female

* Age Group Split: Below 40 Years, Age 40-60 Years, Above 60 Years

* Distribution Channel Split: Online Pharmacies, Retail Pharmacies, Hospital pharmacies and dental clinics

* End-user Split: Home Care Setting/ Individuals, Hospital, Dental Clinics

Key Players:

The report covers major players in the Sleep Apnea Oral Appliances market, including SomnoMed, ResMed, Whole You, Inc., ProSomnus Sleep Technologies, Vivos Therapeutics, Inc., and others.

Recent Developments:

* In 2023, Vivos Therapeutics, Inc. received 510(k) clearance from the U.S. FDA for their DNA appliance, aimed at treating snoring and mild to moderate OSA in adults.

* In 2022, ResMed acquired MEDIFOX DAN to strengthen their position in out-of-hospital software solutions.

* In 2021, SomnoMed conducted SomSUMMIT ’21 to promote oral appliance therapy as a primary solution for successful OSA treatment.

Report Objectives:

The report aims to define and forecast the global Sleep Apnea Oral Appliances market, analyze key market stakeholders, and provide a detailed understanding of the major factors influencing market growth. It also profiles key players and employs a Competitive Leadership Mapping framework to benchmark players in the market based on various parameters of business and product excellence.

For more information, please visit the official report page: Sleep Apnea Oral Appliances Market Report

The information provided here offers a detailed analysis and forecast of the Sleep Apnea Oral Appliances market, catering to the needs of stakeholders seeking insightful market intelligence to make informed decisions and strategies.

Link for reference: Click Here

Back to the blog